News Sentiment

CELU sentiment intelligence

Celularity Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 47 Balanced news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.74 Week of 10 Jul 2026
Weighted tone 47/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+19.5% over one week, +3.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Insider trust lends $1M to Celularity (NASDAQ: CELU) on short term

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction 19.5% Price confirming higher
Trend fit Trend inactive 3.9% over four weeks
Fair value -69.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 44
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 16
Market source 8
TradingView 6
GlobeNewswire 5
simplywall.st 3
MT Newswires 2
Investing.com Nigeria 2
marketscreener.com 2

Event Lens

What the news is about

Classified themes
Market update 37
Earnings 10
Deals and strategy 5
Regulatory and legal 2
Balance sheet 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 57
Stock Titan Direct company coverage

Insider trust lends $1M to Celularity (NASDAQ: CELU) on short term

Celularity Inc. has secured a $1 million short-term loan from the Philip & Daniele Barach Family Trust, an entity linked to a significant shareholder. The loan features a 4.0% annual interest rate, which can rise to 18.0% upon default, and is collateralized by most of Celularity'

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 22:09
Source
Stock Titan
TradingView Direct company coverage

Celularity Inc. Class A Actuals & Estimates (NASDAQ:CELU)

This article provides an overview of Celularity Inc. (NASDAQ: CELU) stock, including its current price, market capitalization, volatility, and historical performance. It also details financial information such as net income, EBITDA, and the upcoming earnings release date, along w

Tone
Negative 8/100
Event
Earnings
Published
25 Jun 2026 14:12
Source
TradingView
Investing.com Nigeria Direct company coverage

Form 4 Celularity Inc For: 23 June By Investing.com

This article confirms that a Form 4 filing for Celularity Inc. was made on June 23rd, as reported by Investing.com. It also briefly mentions Celularity Inc.'s stock symbol CELU and its performance. The rest of the content includes current market data for various indices, commodit

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 19:10
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Celularity (NASDAQ: CELU) insider trust sees $2M note option expire

A Form 4 filing reveals that options held by The Philip & Daniele Barach Family Trust, a ten percent owner of Celularity (NASDAQ: CELU), to purchase up to $2,000,000 in convertible notes and 839,160 related warrants, expired on June 19, 2026. The expiration occurred as per the te

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 14:11
Source
Stock Titan
Stock Titan Direct company coverage

Barach Family Trust (CELU) lets $2M note, warrant options lapse while holding large derivatives

The Philip & Daniele Barach Family Trust, a 10% owner of Celularity Inc. (CELU), reported that options to purchase $2 million in convertible notes and 839,160 warrants expired on June 19, 2026, without consideration. Despite these expirations, the trust maintains significant hold

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 14:11
Source
Stock Titan
Stock Titan Direct company coverage

Celularity (NASDAQ: CELU) major holder’s $2M note option and 839K warrants expire

A major shareholder of Celularity Inc., Daniele Wolf Barach, through the Philip & Daniele Barach Family Trust, reported the expiration of options to purchase up to $2 million in convertible notes and rights to obtain 839,160 warrants. These options expired on June 19, 2026, witho

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 14:11
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 13D/A Celularity Inc. For: 23 June By Investing.com

This article announces the filing of Form 13D/A by Celularity Inc. on June 23, 2026. Form 13D/A is a regulatory filing indicating a change in beneficial ownership of a company's shares. The article provides no further details about the filing's content.

Tone
Neutral 50/100
Event
Regulatory and legal
Published
23 Jun 2026 07:09
Source
Investing.com Nigeria
Investing.com South Africa Direct company coverage

Celularity receives Nasdaq notice for non-compliance with $35 million market value rule By Investing.com

Celularity Inc. announced it received a Nasdaq notice for failing to maintain a minimum market value of $35 million for 30 consecutive business days. The company has 180 calendar days, until December 7, 2026, to regain compliance by having its market value of listed securities re

Tone
Negative 20/100
Event
Market update
Published
13 Jun 2026 15:41
Source
Investing.com South Africa
Investing.com Canada Direct company coverage

Celularity receives Nasdaq notice for non-compliance with $35 million market value rule

Celularity Inc. received a notice from Nasdaq for failing to meet the minimum market value of listed securities requirement of $35 million. The company has 180 calendar days, until December 7, 2026, to regain compliance, either by increasing its market value or by meeting alterna

Tone
Negative 37/100
Event
Market update
Published
13 Jun 2026 02:40
Source
Investing.com Canada
Stock Titan Direct company coverage

[8-K] Celularity Inc Reports Material Event

Celularity Inc. (CELU) has received a notice from Nasdaq stating that its Market Value of Listed Securities has fallen below the required $35 million minimum for 30 consecutive business days. The company has 180 calendar days, until December 7, 2026, to regain compliance by maint

Tone
Negative 18/100
Event
Market update
Published
12 Jun 2026 21:09
Source
Stock Titan
marketscreener.com Direct company coverage

Celularity Inc. Appoints Rick Gonzalez as Chief Commercial Officer, Effective May 29, 2026

Celularity Inc. has appointed Rick Gonzalez as its Chief Commercial Officer, effective May 29, 2026. In this role, Mr. Gonzalez will lead the global commercial strategy for cenplacel-L, Lifebank, and the company's broader regenerative medicine portfolio. He brings over two decade

Tone
Positive 67/100
Event
Market update
Published
01 Jun 2026 05:41
Source
marketscreener.com
TradingView Direct company coverage

CELU Stock Price and Chart — NASDAQ:CELU

Celularity Inc. (NASDAQ: CELU) is a clinical-stage biotechnology company focused on developing allogeneic cell therapies from placental-derived sources for cancer, immune, and infectious diseases, operating through Cell Therapy, BioBanking, and Degenerative Disease segments. The

Tone
Neutral 50/100
Event
Market update
Published
31 May 2026 08:10
Source
TradingView
Market source Direct company coverage

Celularity Receives Nasdaq Notice Regarding Form 10-Q

Celularity Inc. announced it received a Nasdaq notification for non-compliance with Listing Rule 5250(c)(1) due to a delayed filing of its quarterly report on Form 10-Q. The company has 60 days to submit a compliance plan and is actively working to file the report as soon as prac

Tone
Negative 39/100
Event
Market update
Published
29 May 2026 17:15
Source
Market source
Stock Titan Direct company coverage

Celularity (NASDAQ: CELU) restructures Helena preferred stock deal with cash and note rights

Celularity Inc. has settled a dispute with Helena Global Investment Opportunities 1 Ltd. regarding prior financing documents. The agreement involves Helena surrendering its Series A Convertible Preferred Stock in exchange for cash payments totaling $1 million ($500,000 immediatel

Tone
Neutral 50/100
Event
Deals and strategy
Published
29 May 2026 08:39
Source
Stock Titan
Simply Wall Street Direct company coverage

Celularity (Nasdaq:CELU) - Stock Analysis

This Simply Wall St analysis provides a detailed stock report for Celularity (Nasdaq:CELU), a regenerative and cellular medicines company, as of May 2026. The report covers valuation, future growth, past performance, financial health, dividend, management, and ownership, indicati

Tone
Negative 40/100
Event
Capital return
Published
14 May 2026 13:10
Source
Simply Wall Street